{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:07:02Z","timestamp":1761156422737},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T00:00:00Z","timestamp":1515628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"genematrix"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00705-017-3687-4","type":"journal-article","created":{"date-parts":[[2018,1,11]],"date-time":"2018-01-11T05:05:09Z","timestamp":1515647109000},"page":"969-976","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative evaluation of the Omniplex-HPV and RFMP HPV PapilloTyper for detecting human papillomavirus genotypes in cervical specimens"],"prefix":"10.1007","volume":"163","author":[{"given":"Young Ahn","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Hak","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwi Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,11]]},"reference":[{"key":"3687_CR1","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4143\/crt.2016.089","volume":"48","author":"CM Oh","year":"2016","unstructured":"Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK et al (2016) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat 48:436\u2013450","journal-title":"Cancer Res Treat"},{"key":"3687_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319","journal-title":"J Pathol"},{"key":"3687_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/jcp.50.8.625","volume":"50","author":"P Tilston","year":"1997","unstructured":"Tilston P (1997) Anal human papillomavirus and anal cancer. J Clin Pathol 50:625\u2013634","journal-title":"J Clin Pathol"},{"issue":"Suppl 1","key":"3687_CR4","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jcv.2015.10.023","volume":"76","author":"M Poljak","year":"2016","unstructured":"Poljak M, Kocjan BJ, Ostrbenk A, Seme K (2016) Commercially available molecular tests for human papillomaviruses (HPV): 2015 update. J Clin Virol 76(Suppl 1):S3\u2013S13","journal-title":"J Clin Virol"},{"key":"3687_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3802\/jgo.2015.26.3.232","volume":"26","author":"KJ Min","year":"2015","unstructured":"Min KJ, Lee YJ, Suh M, Yoo CW, Lim MC, Choi J et al (2015) The Korean guideline for cervical cancer screening. J Gynecol Oncol 26:232\u2013239","journal-title":"J Gynecol Oncol"},{"key":"3687_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3322\/caac.21261","volume":"65","author":"RA Smith","year":"2015","unstructured":"Smith RA, Manassaram-Baptiste D, Brooks D, Doroshenk M, Fedewa S, Saslow D et al (2015) Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin 65:30\u201354","journal-title":"CA Cancer J Clin"},{"key":"3687_CR7","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","volume":"287","author":"D Solomon","year":"2002","unstructured":"Solomon D, Davey D, Kurman R, Moriarty A, O\u2019Connor D, Prey M et al (2002) The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287:2114\u20132119","journal-title":"JAMA"},{"key":"3687_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F et al (2009) A review of human carcinogens\u2014part B: biological agents. Lancet Oncol 10:321\u2013322","journal-title":"Lancet Oncol"},{"key":"3687_CR9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518\u2013527","journal-title":"N Engl J Med"},{"key":"3687_CR10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/jmv.21992","volume":"83","author":"HP Lee","year":"2011","unstructured":"Lee HP, Kim SO, Hwang TS, Bae JM, Kim SN, Kim JW et al (2011) Analytical and clinical performances of a restriction fragment mass polymorphism assay for detection and genotyping of a wide spectrum of human papillomaviruses. J Med Virol 83:471\u2013482","journal-title":"J Med Virol"},{"key":"3687_CR11","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/jmv.24206","volume":"87","author":"S Yu","year":"2015","unstructured":"Yu S, Kwon MJ, Lee EH, Park H, Woo HY (2015) Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus. J Med Virol 87:1587\u20131593","journal-title":"J Med Virol"},{"key":"3687_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","volume":"38","author":"PE Gravitt","year":"2000","unstructured":"Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A et al (2000) Improved amplification of genital human papillomaviruses. J Clin Microbiol 38:357\u2013361","journal-title":"J Clin Microbiol"},{"key":"3687_CR13","first-page":"439","volume":"40","author":"HJ Chung","year":"2006","unstructured":"Chung HJ, Kim SN, Lee EH, Jee MS, Kim MA, Hwang SY et al (2006) Comparison of efficacy of human papilloma virus genotyping assays using restriction fragment mass polymorphism and DNA chip analysis in patients with abnormal pap smear and uterine cervical cancer. Korean J Pathol 40:439\u2013447","journal-title":"Korean J Pathol DE"},{"key":"3687_CR14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jcv.2013.01.014","volume":"57","author":"HP Lee","year":"2013","unstructured":"Lee HP, Cho W, Bae JM, Shin JY, Shin SK, Hwang SY et al (2013) Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping. J Clin Virol 57:130\u2013135","journal-title":"J Clin Virol"},{"key":"3687_CR15","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1086\/382896","volume":"189","author":"T Asato","year":"2004","unstructured":"Asato T, Maehama T, Nagai Y, Kanazawa K, Uezato H, Kariya K (2004) A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. J Infect Dis 189:1829\u20131832","journal-title":"J Infect Dis"},{"key":"3687_CR16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1128\/JCM.38.2.651-655.2000","volume":"38","author":"SD Vernon","year":"2000","unstructured":"Vernon SD, Unger ER, Williams D (2000) Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 38:651\u2013655","journal-title":"J Clin Microbiol"},{"key":"3687_CR17","doi-asserted-by":"publisher","first-page":"e32259","DOI":"10.1371\/journal.pone.0032259","volume":"7","author":"MY Chung","year":"2012","unstructured":"Chung MY, Kim YW, Bae SM, Kwon EH, Chaturvedi PK, Battogtokh G et al (2012) Development of a bead-based multiplex genotyping method for diagnostic characterization of HPV infection. PLoS One 7:e32259","journal-title":"PLoS One"},{"key":"3687_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1128\/JCM.01170-12","volume":"51","author":"J Peng","year":"2013","unstructured":"Peng J, Gao L, Guo J, Wang T, Wang L, Yao Q et al (2013) Type-specific detection of 30 oncogenic human papillomaviruses by genotyping both E6 and L1 genes. J Clin Microbiol 51:402\u2013408","journal-title":"J Clin Microbiol"},{"key":"3687_CR19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1365-2303.2010.00754.x","volume":"21","author":"EL Moss","year":"2010","unstructured":"Moss EL, Moran A, Douce G, Parkes J, Todd RW, Redman CW (2010) Cervical cytology\/histology discrepancy: a 4-year review of patient outcome. Cytopathology 21:389\u2013394","journal-title":"Cytopathology"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-017-3687-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3687-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3687-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T05:14:51Z","timestamp":1660281291000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-017-3687-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,11]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["3687"],"URL":"https:\/\/doi.org\/10.1007\/s00705-017-3687-4","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,11]]},"assertion":[{"value":"25 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was funded by Genematrix Inc. which is the company producing both HPV-assays, therefore this should be stated as a conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}